Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Frontiers in Oncology|July 30, 2019
The Statistical Evaluation of Treatment and Outcomes in Head and Neck Squamous Cell Carcinoma Clinical TrialsCatherine Fortpied, Marie Vinches
Anti-Cancer Drugs|June 29, 2011
Design issues in head and neck clinical trials: a statistician's perspectiveCatherine Fortpied, Cecilia Liberatoscioli, Jan Bogaerts
European Journal of Haematology|October 15, 2010
Gem-(R)CHOP versus (R)CHOP: a randomized phase II study of gemcitabine combined with (R)CHOP in untreated aggressive non-Hodgkin's lymphoma--EORTC lymphoma group protocol 20021 (EudraCT number 2004-004635-54)Igor Aurer, Houchingue Eghbali, John Raemaekers, et al.
Mediterranean Journal of Hematology and Infectious Diseases|November 7, 2015
Efficacy and Safety of Cladribine: Subcutaneous versus Intravenous Administration in Hairy Cell Leukemia PatientsOla Khorshid, Alfred Elias Namour, Mosaad M El-Gammal, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2021
Prognostic factor analysis and long-term results of the TAX 323 (EORTC 24971) study in unresectable head and neck cancer patientsPetr Szturz, Marie Vinches, Éva Remenár, et al.
Journal of Geriatric Oncology|May 17, 2021
Treatment patterns in older patients with locally advanced head and neck squamous cell carcinoma: Results from an EORTC led surveySjoukje F Oosting, Isacco Desideri, Dominiek Staelens, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 20, 2012
EORTC 24051: unexpected side effects in a phase I study of TPF induction chemotherapy followed by chemoradiation with lapatinib, a dual EGFR/ErbB2 inhibitor, in patients with locally advanced resectable larynx and hypopharynx squamous cell carcinomaYassine Lalami, Pol M Specenier, Ahmad Awada, et al.
Blood Advances|January 8, 2025
Maximum tumor diameter is associated with relapse risk in limited-stage Hodgkin lymphoma: an international studyElizabeth H Phillips, Nicholas Counsell, Tim Illidge, et al.
British Journal of Haematology|December 21, 2022
Relapse patterns in early-PET negative, limited-stage Hodgkin lymphoma (HL) after ABVD with or without radiotherapy-a joint analysis of EORTC/LYSA/FIL H10 and NCRI RAPID trialsValeria Fiaccadori, Anouk Neven, Catherine Fortpied, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 2, 2023
Tumor Microenvironment Modifications Induced by Afatinib in Squamous Cell Carcinoma of the Head and Neck: A Window-of-Opportunity Study (EORTC-90111-24111)Simon P Beyaert, Axelle E Loriot, Nicolas D Huyghe, et al.
Pageof 5